Heartgard For Dogs label

Heartgard For Dogs

Heartgard For Dogs Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

Caution: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

There is currently no usage information available for this product. We apologize for any inconvenience.

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Heartgard For Dogs Manufacturers

  • Merial Limited
    Heartgard For Dogs | Merial Limited
    No Recall

    Heartgard For Dogs | Merial Limited

    Heartgard For Dogs | Merial Limited

    DOSAGE: HEARTGARD Tablets should be administered orally at monthly intervals at the recommended minimum dose level of 6 mcg of ivermectin per kilogram (2.72 mcg/lb) of body weight. (See ADMINISTRATION). The recommended dosage schedule for prevention of canine heartworm disease is as follows:

      Dog Weight Tablets Per Month Ivermectin Per Tablet Color on Carton Give dogs over 100 lb the appropriate combination of tablets.
    HEARTGARD is recommended for use in dogs 6 weeks of age and older. Up to 25 lb 1   68 mcg Blue 26 to 50 lb 1 136 mcg Green 51 to 100 lb 1 272 mcg Brown

    ADMINISTRATION: The HEARTGARD tablet should be given so that dogs swallow the whole tablet. (The tablet may be wrapped in food to encourage consumption.) Care should be taken to see that the dog consumes the complete dose, and treated animals should be observed for a few minutes after administration to ensure that part of the dose is not lost or rejected. If it is suspected that any of the dose has been lost, redosing is recommended. HEARTGARD Tablets should be given at monthly intervals during the period of the year when mosquitoes (vectors), potentially carrying infective heartworm larvae, are active. The initial dose must be given within a month (30 days) after the first exposure to mosquitoes. The final dose must be given within a month (30 days) after the last exposure to mosquitoes.

    When replacing another heartworm preventive in a heartworm disease preventive program, the first dose of HEARTGARD must be given within a month (30 days) after the last dose of the former medication.

    If the interval between doses exceeds a month (30 days), the efficacy of ivermectin can be reduced. For optimal performance, the tablet must be given once a month on or about the same day of the month. If treatment is delayed, whether by a few days or many, immediate treatment with HEARTGARD and resumption of the recommended dosing regimen minimizes the opportunity for the development of adult heartworms.